Wealthfront Advisers’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-6,269
| Closed | -$1.15M | – | 716 |
|
|
2021
Q2 | $1.15M | Buy |
6,269
+1,598
| +34% | +$294K | 0.01% | 412 |
|
|
2021
Q1 | $714K | Buy |
4,671
+917
| +24% | +$140K | ﹤0.01% | 416 |
|
|
2020
Q4 | $587K | Buy |
3,754
+370
| +11% | +$57.9K | ﹤0.01% | 416 |
|
|
2020
Q3 | $387K | Buy |
3,384
+224
| +7% | +$25.6K | ﹤0.01% | 432 |
|
|
2020
Q2 | $355K | Buy |
+3,160
| New | +$355K | ﹤0.01% | 432 |
|
|
2019
Q3 | – | Sell |
-2,113
| Closed | -$277K | – | 496 |
|
|
2019
Q2 | $277K | Sell |
2,113
-679
| -24% | -$89K | ﹤0.01% | 448 |
|
|
2019
Q1 | $377K | Buy |
+2,792
| New | +$377K | ﹤0.01% | 403 |
|